DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+5.96%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$30.1B
AUM Growth
+$3.48B
(+13%)
Cap. Flow
+$2.16B
Cap. Flow
% of AUM
7.16%
Top 10 Holdings %
Top 10 Hldgs %
23.19%
Holding
1,423
New
92
Increased
671
Reduced
310
Closed
81
Top Buys
| 1 |
Intel
INTC
|
+$115M |
| 2 |
Salesforce
CRM
|
+$95.7M |
| 3 |
Johnson & Johnson
JNJ
|
+$95M |
| 4 |
Microsoft
MSFT
|
+$89.5M |
| 5 |
Citigroup
C
|
+$77M |
Top Sells
| 1 |
CMS Energy
CMS
|
+$70.3M |
| 2 |
Amgen
AMGN
|
+$68.6M |
| 3 |
Ameren
AEE
|
+$66.6M |
| 4 |
NVIDIA
NVDA
|
+$63.6M |
| 5 |
Fidelity National Information Services
FIS
|
+$55.7M |
Sector Composition
| 1 | Technology | 24.75% |
| 2 | Healthcare | 15.88% |
| 3 | Financials | 12.34% |
| 4 | Communication Services | 9.65% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Stoke Therapeutics
STOK
$1.21B
| $328K | ﹤0.01% |
8,900
| – | – |
|
1102
Carlyle Group
CG
$23.2B
| $327K | ﹤0.01% |
8,915
+22
| +0.2% | +$807 |
|
1103
Mersana Therapeutics
MRSN
$35.1M
| $326K | ﹤0.01% |
840
| – | – |
|
|
ITOS
1104
DELISTED
iTeos Therapeutics
ITOS
| $324K | ﹤0.01% |
10,000
| – | – |
|
1105
Akebia Therapeutics
AKBA
$830M
| $317K | ﹤0.01% |
102,100
| – | – |
|
1106
Bausch Health
BHC
$2.71B
| $315K | ﹤0.01% |
10,203
-700
| -6% | -$21.6K |
|
1107
Encompass Health
EHC
$12.7B
| $315K | ﹤0.01% |
4,777
+3,583
| +300% | +$236K |
|
1108
iQIYI
IQ
$2.69B
| $315K | ﹤0.01% |
17,557
+4,452
| +34% | +$79.9K |
|
1109
Arcturus Therapeutics
ARCT
$484M
| $314K | ﹤0.01% |
8,100
| – | – |
|
|
RDUS
1110
DELISTED
Radius Health, Inc.
RDUS
| $312K | ﹤0.01% |
15,200
| – | – |
|
|
CNST
1111
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $311K | ﹤0.01% |
13,300
| – | – |
|
|
AIV
1112
Aimco
AIV
$1.1B
| $309K | ﹤0.01% |
50,710
+48,123
| +1,860% | +$293K |
|
1113
Hexcel
HXL
$5.12B
| $309K | ﹤0.01% |
5,460
+2,515
| +85% | +$142K |
|
1114
Precigen
PGEN
$1.24B
| $309K | ﹤0.01% |
46,500
| – | – |
|
1115
Gildan
GIL
$8.19B
| $308K | ﹤0.01% |
10,066
+1,381
| +16% | +$42.3K |
|
1116
Rocket Companies
RKT
$43.1B
| $302K | ﹤0.01% |
+13,107
| New | +$302K |
|
1117
Zions Bancorporation
ZION
$8.42B
| $298K | ﹤0.01% |
5,342
-249
| -4% | -$13.9K |
|
1118
Annexon
ANNX
$243M
| $297K | ﹤0.01% |
12,000
| – | – |
|
1119
Standard Motor Products
SMP
$893M
| $297K | ﹤0.01% |
6,784
+2,987
| +79% | +$131K |
|
1120
Banco Santander Chile
BSAC
$11.9B
| $296K | ﹤0.01% |
12,100
| – | – |
|
1121
Itaú Unibanco
ITUB
$76B
| $293K | ﹤0.01% |
80,253
+26,686
| +50% | +$97.4K |
|
1122
Ovintiv
OVV
$10.6B
| $291K | ﹤0.01% |
12,000
-1,000
| -8% | -$24.3K |
|
1123
Gentherm
THRM
$1.12B
| $285K | ﹤0.01% |
3,942
| – | – |
|
1124
Avidity Biosciences
RNA
$6.18B
| $284K | ﹤0.01% |
14,000
| – | – |
|
1125
St. Joe Company
JOE
$3.05B
| $282K | ﹤0.01% |
6,450
| – | – |
|